Schatz supports making drug companies pay more for Medicare, but Hanabusa worries it will drive up premiums.

Loading Hanabusa And Schatz Differ Over Making Drug Companies Pay

Follow Civil Beat on Facebook and Twitter. You can also sign up for Civil Beat’s free daily newsletter.

Comments